• About us
• Contact

Advertisement

Organisation › Details

Tusk Therapeutics Ltd.

Tusk Therapeutics is a privately held immuno-oncology company focused on discovering and developing therapeutic antibodies that harness the power of the immune system to transform the treatment of cancer. The Company’s lead programme consists of a first-in-class antibody for the depletion of regulatory T-cells, based on the work of Dr. Sergio Quezada. The Company has strategic partnerships and licensing agreements with top research institutes including Cancer Research Technology, Cancer Research UK’s commercial arm and University College London. *

 

	Start	2014-01-01 established
	Group	Roche (Group)
	Industry	cancer immunotherapy (immuno-oncology, I-O)
	Person	Dochez, Luc (Vico Therapeutics 202007 CEO + Co-Founder + Droia Genetic Disease Fund Managing Partner before Prosensa)
	Street	Gunnels Wood Road Stevenage Bioscience Catalyst
	City	SG1 2FX Stevenage, Hertfordshire
		Address record changed: 2020-12-02
Basic data	Employees	B: 11 to 50 (2017-12-18)
		* Document for »About Section«:
		Record changed: 2025-03-16

Advertisement

More documents for Roche (Group)

• [1] Forbion Capital Partners. (7/20/22). "Press Release: Forbion Appoints Dr. Peter Høngaard Andersen as Operating Partner and Dr. Matt Cooper as Venture Partner". Naarden....
• [2] Affimed N.V.. (4/8/22). "Press Release: Affimed Presents Findings from the Dose-escalation Phase of the First-in-human Study of AFM24 in Patients with EGFR-positive Solid Tumors". Heidelberg....
• [3] Roche. (2/1/22). "Press Release: Changes to the Roche Board of Directors and the Corporate Executive Committee". Basel....
• [4] Mainz Biomed N.V.. (11/11/21). "Press Release: Mainz Biomed Appoints Former Roche Division President Heiner Dreismann to Strategic Advisory Board". Berkeley, CA & Mainz....
• [5] Mimetas B.V.. (7/6/21). "Press Release: Mimetas and Roche Enter into a Collaboration to Develop Human Disease Models for Drug Development". Leiden....
• [6] Agilent Technologies Inc.. (1/15/21). "Press Release: Agilent Names Allison Ballmer Senior Vice President of Corporate Development". Santa Clara, CA....
• [7] Sophia Genetics S.A.. (11/17/20). "Press Release: Bram Goorden Joins Sophia Genetics as Chief Commercial Officer and Head of North America". Boston, MA & Lausanne....
• [8] Lead Pharma Holding B.V.. (11/16/20). "Press Release: Lead Pharma Enters into a Research Collaboration and License Agreement with Roche to Develop Oral Small Molecules for Immune Mediated Diseases"....
• [9] Atbtherapeutics. (10/20/20). "Press Release: Atbtherapeutics Strengthens Its Scientific Advisory Board to Support the Development of its Novel Platform and Portfolio". Belgium....
• [10] Argenx SE. (10/6/20). "Press Release: Argenx Expands Capabilities In Antibody Engineering Through Key Technology Partnerships". Breda & Ghent....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.